Management Team

  • Philip Breitfeld, MD

    Chief Medical Officer

    Over 30 years of oncology drug development experience across academia, pharma, biotech and CROs including Merck KGaA and Quintiles.

    in
  • Sougata Dey, PhD

    Director of Chemistry

    Specializes in oligonucleotide therapeutics, with expertise in radiochemistry, synthetic medicinal chemistry, molecular biology, and nucleic acid chemistry. 15+ years of experience.

    in
  • Jagruti Harkleroad

    Program Analyst

    Jagruti is an accomplished biomedical researcher with nearly a decade of experience in drug discovery, preclinical development, and project management.

    in
  • Michael J. Heffernan, PhD, PE

    Vice President of Operations

    Over 30 years research, product development and operations experience at large and startup company settings.

    in
  • Secondra Holmes, PhD

    Product Development Associate

    Expert in pharmacology and chemical biology with over a decade of drug discovery experience.

    in
  • Serena Miggins, MA

    Business Operations Manager

    Serena brings over a decade of experience in optimizing business processes and driving operational excellence.

    in
  • Uksha Saini, PhD

    Senior Scientist, Non-Clinical

    Over 15 years of oncology research and drug development experience across multiple cancers.

    in
  • Atul Varadhachary, MD, PhD

    Chief Executive Officer

    25 years of oncology drug development including a Phase 3 exit. Veteran of Agennix, Reliance Life Sciences, McKinsey, and Fannin.

    in
  • Mark Worscheh, MBA

    Chief Financial Officer

    As an investment banker and seasoned financial executive, Mark brings a wealth of expertise to the role of CFO, having successfully steered the financial strategies of multiple venture-backed startups over the past 25 years.

    in